Quick Answer
IDEXX LABORATORIES INC /DE reported Operating Income Loss of $1.36 billion for the year ending 2025.
- IDEXX LABORATORIES INC /DE showed an increase of +20.5% in Operating Income Loss from 2024 to 2025.
- This data is from IDEXX LABORATORIES INC /DE's annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), IDEXX LABORATORIES INC /DE's Operating Income Loss has grown by 688.6%.
- Historical annual values: Fiscal year 2025: $1.36 billion | Fiscal year 2024: $1.13 billion | Fiscal year 2023: $1.10 billion | Fiscal year 2022: $898.77 million | Fiscal year 2021: $932.03 million | Fiscal year 2020: $694.52 million | Fiscal year 2019: $552.85 million | Fiscal year 2018: $491.34 million | Fiscal year 2017: $413.03 million | Fiscal year 2016: $350.24 million | Fiscal year 2015: $299.91 million | Fiscal year 2014: $260.26 million | Fiscal year 2013: $266.76 million | Fiscal year 2012: $262.56 million | Fiscal year 2011: $236.23 million | Fiscal year 2010: $203.88 million | Fiscal year 2009: $175.97 million | Fiscal year 2008: $172.46 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: